$63.81
-1.88 (-2.86%)
Open$67.59
Previous Close$65.69
Day High$68.00
Day Low$63.81
52W High$97.97
52W Low$28.81
Volume—
Avg Volume37.9K
Market Cap199.71M
P/E Ratio—
EPS$-5.64
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
-80.6% upside
Current
$63.81
$63.81
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.78M | 12.74M | 80.43M |
| Net Income | -6,883,417 | -3,623,698 | 27.17M |
| Profit Margin | -31.6% | -30.0% | 33.8% |
| EBITDA | -8,346,296 | -4,637,916 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | +71.0% | +71.0% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |